Home  >  Speakers  >  Jay Ivan Meltzer
Jay Ivan Meltzer

Jay Ivan Meltzer MD

Professor | New York, New York    United States of America
Renal Medicine Disease And Hypertension , Nephrology
Nephrology, Renal Medicine Disease,...More
Spoken at 1 event

Biography :

Meltzer joined the clinic staff full time in 1959 after joining the faculty as a clinical instructor and the hospital as an attending physician. He continued to work in John Laragh’s lab and its clinical unit the “Metabolism Ward,” while in full time clinical practice. Dr. Bradley viewed all kidney disease as Bright’s Disease and worked on its natural history. The only treatment for hypertension was bilateral thoraco-lumbar sympathectomy for malignant hypertension, rawolfia serpentine for the benign form, and finding a “secondary cause”: pheochromocytoma, adrenal tumors and something called unilateral renal disease.

Hemodialysis was in early use for the treatment of acute reversible renal failure, mostly in Europe, and only at Cornell-Bellevue in New York. The most important clinical necessity for the large dialysis centers was triage of the legions of referred renal failure patients between acute, potentially reversible, renal failure and end-stage irreversible disease. The only reliable clinical tool for this critical distinction was renal biopsy, which literally decided life and death. In 1959, Brun and Iversen in Copenhagen used the liver needle with the patient sitting and someone’s fist in the anterior flank to stabilize the biopsied organ. Clinical Nephrology began then. Bright’s Disease disappeared into an organized confusion of new pathologically designated renal diseases, but the scientific basis of a nephrology specialty was stablished.

**********************
** ************
This section has yet to be updated by the speaker.
For speaker's contact information - Contact us

Specialties

Renal Medicine Disease and Hypertension , Nephrology

Interested Topics

Nephrology, Renal Medicine Disease, Hypertension, Kidney Disease, Bilateral Thoraco-Lumbar Sympathectomy, Pheochromocytoma, Renal Failure, Hemodialysis, Copenhagen, Biopsied Organ

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
MOC / CME / CE Requirements
Connecticut Medical Examining Board

Connecticut Medical Examining Board accepts the credit courses that are accredited by ACCME and awards AMA PRA Category 1 Credit.

MD/DO Requirement:

CME Credits Required : 50.00 | Licensing Cycle AMA PRA : 2 Years | Category Credits : 0.00

A minimum of 50 contact hours of qualifying continuing medical education every 2 years commencing on the first date of license renewal;1 contact hour means a minimum of 50 minutes of the continuing education activity once every 6 years.1 CME hour in each of the following topics:

(A) Infectious diseases, including, but not limited to, acquired immune deficiency syndrome and human immunodeficiency virus,
(B) risk management,
(C) sexual assault,
(D) domestic violence,
(E) cultural competency,
(F) behavioral health.

Beginning January 1, 2020, such behavioral health CME must include at least 2 contact hours on diagnosing and treating (i) cognitive conditions, including, but not limited to, Alzheimer’s disease, dementia, delirium, related cognitive impairments, and geriatric depression, or (ii) mental health conditions, including, but not limited to, those common to veterans and family members of veterans such as post-traumatic stress, risk of suicide, depression, and grief. OCC/MOC not accepted as a substitute. The commissioner may grant a waiver for not more than 10 contact hours of CME for physicians who:

(1) engage in activities related to the physician’s service as a member of the Connecticut Medical Examining Board,
(2) engage in activities related to the physician’s service as a member of a medical healing panel, or
(3) assist the state Department of Public Health with its duties to board and commissions (described in Ch. 368a. Sec. 10a-14).